Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anxiety Disorders × Niacin × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hand-Foot Skin Reaction (HFSR) 1 Depression 1 Anxiety Disorders 1

Interventions

Psilocybin 4 Psychotherapy 2 Fluoxetine 2 Cannabidiol 2 nabiximols 1 Yoga 1 Therapeutics 1 Pharmaceutical Preparations 1 Niacin 1 Neoadjuvant Therapy 1 N-Methyl-3,4-methylenedioxyamphetamine 1 Minocycline 1 Medical Marijuana 1 Ketamine 1 Injections 1 Hormones 1 Gemcitabine 1 Dronabinol 1 Donepezil 1 Citalopram 1 Cisplatin 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06200155 2026-03-03

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

M.D. Anderson Cancer Center

Phase 2 Recruiting

Anxiety Disorders, Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡